JW Holdings Corporation

We, JW Holdings, are moving forward toward global healthcare group. JW Holdings, as a holding company, we are concentrating all our efforts to ensure stable growth of business companies including JW Pharmaceutical, JW Shinyak, JW Life Science, JW Medical. JW Holdings, a business holding company, directly handles overseas business for raw materials, finished pharmaceuticals, medical device and etc. produced by subsidiaries. JW Holdings also generate profits from management services, subsidiaries’ equity interest, brand royalties, service fees from subsidiary companies. More over, JW Holdings focus on establishing a vision so each business unit can gain competitiveness and create synergies that grow into a global healthcare group.

Established in Vietnam since 1996, JW Holdings Corporation Representative Office (former JW Pharmaceutical Representative Office and Choongwae Pharma Corporation Representative Office ) has received the high appraisal of doctors & pharmacists nation wide. We have provided high quality and effective therapeutic products to pharmacies and hospitals through distributors.

On November 13, 2019, JW Holdings hosted an inauguration ceremony for Euvipharm Joint Stock Company, in Long An Province, Vietnam. It is the first time ever for a Korean company to acquire the entire equity of Vietnamese pharmaceutical company for direct operation, and JW Holdings is now fully mobilizing its strategy to expand into Pharmerging markets throughout the ASEAN nations, including Vietnam, based on pharmaceutical products produced by Euvipharm.

We will make commitment to making our society bright and healthy by producing and Supplying innovative technologies, products and services which will support for healthy life Of the people, and will pursue the satisfaction and happiness of customers, shareholders and the employees through our trustworthy activities.